These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 28356124
21. Unresectable Clival Giant Cell Tumor, Tumor Control With Denosumab After Relapse: A Case Report and Systematic Review of the Literature. Pionelli MG, Asaftei SD, Tirtei E, Campello A, Di Rosa G, Fagioli F. J Pediatr Hematol Oncol; 2022 Jul 01; 44(5):201-209. PubMed ID: 35537059 [Abstract] [Full Text] [Related]
23. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery. von Borstel D, A Taguibao R, A Strle N, E Burns J. Skeletal Radiol; 2017 Apr 01; 46(4):571-578. PubMed ID: 28188337 [Abstract] [Full Text] [Related]
24. Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone. Rosario M, Takeuchi A, Yamamoto N, Hayashi K, Miwa S, Higuchi T, Abe K, Taniguchi Y, Aiba H, Tanzawa Y, Murakami H, Tsuchiya H. Anticancer Res; 2017 Feb 01; 37(2):749-754. PubMed ID: 28179326 [Abstract] [Full Text] [Related]
25. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series. Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R. World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843 [Abstract] [Full Text] [Related]
26. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H. Eur Spine J; 2017 May 04; 26(Suppl 1):236-242. PubMed ID: 28396950 [Abstract] [Full Text] [Related]
28. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases. Deveci MA, Paydaş S, Gönlüşen G, Özkan C, Biçer ÖS, Tekin M. Acta Orthop Traumatol Turc; 2017 Jan 04; 51(1):1-6. PubMed ID: 27784623 [Abstract] [Full Text] [Related]
29. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH. Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590 [Abstract] [Full Text] [Related]
30. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases. Kumar R, Mallya V, Mandal S, Tomar R, Khurana N, Maini L. J Cancer Res Ther; 2023 Jun 08; 19(3):768-772. PubMed ID: 37470608 [Abstract] [Full Text] [Related]
34. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India. Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A. Pathol Oncol Res; 2017 Jan 08; 23(1):157-164. PubMed ID: 27722984 [Abstract] [Full Text] [Related]
35. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial. Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T. Ann Oncol; 2015 Oct 08; 26(10):2149-54. PubMed ID: 26205395 [Abstract] [Full Text] [Related]
38. [Treatment progress on giant cell tumors of bone]. Liang P. Zhongguo Gu Shang; 2018 Mar 25; 31(3):292-296. PubMed ID: 29600686 [Abstract] [Full Text] [Related]
39. How safe and effective is denosumab for bone giant cell tumour? Errani C, Tsukamoto S, Mavrogenis AF. Int Orthop; 2017 Nov 25; 41(11):2397-2400. PubMed ID: 28646421 [Abstract] [Full Text] [Related]